ChrétiénM., LiC.H.: Isolation, purification and characterization of gammalipotropic hormone from sheep pituitary glands.Can J Biochem, 45: 1163, 1967.
2.
CleghornR.A.: Morphine-like peptides of brain and their relation to hormonal neuro-transmitters.Psychiat J Univ Ottawa II, 3: 133–137, 1977.
3.
CuelloA.C.: Endogenous opioid peptides in neurons of the human brain.Lancet, pp. 291–295, August 5, 1978.
4.
de WiedD., BohusB., GispenW.H., UrbanI., Van Wimersma GreidanusTj.B.: “Hormonal Influences on Motivational Learning and Memory Processes” in, SacherE.J., (ed): Hormones, Behavior and Psychopathology.New York: Raven Press, 1976.
5.
de WiedD.: “Effects of Peptide Hormones in Behavior Frontiers” in, GanongW.F., MartiniL., (eds): Neuroendocrinology.London: Oxford University Press, 1969.
6.
de WiedD.: Hormonal influences on motivation, learning and memory processes.Hosp Tract, January, 1976, pp. 123–131.
7.
de WiedD.: Schizophrenia as an inborn error in the degradation of B-Endorphin —a hypothesis.TINS, March 1979, pp. 79–82.
8.
GoldsteinA.: Endorphins. The sciences.N Y Acad Sci, March, 1978, pp. 14–19.
9.
GoldsteinA., LowneyL.I., PalB.K.: Stereospecific and non-specific interactions of the morphine congener levarphonol in subcellular fractions of mouse brain.Proc Natl Acad Sci USA68: 1742, 1971.
10.
GoodmanL.S., GilmanA.: The Pharmacological Basis of Therapeutics.New York: MacMillan, 1975.
11.
GuilleminR., BurgusR.: The hormones of the hypothalamus.Sci Am, 227: 24–33, 1972.
12.
GuilleminR., LingN., LazarusL., BurgusR., MinickS., BloomF., NicollR., Siggins: The endorphins, novel peptides of brain and hypophyseal origin, with opiate-like activity. Biochemical and biological studies, Ann N Y Acad Sci, 297: 131–157, Oct. 28, 1977.
13.
GuilleminR., VargoT., RossierJ.,: B-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland.Science, 197: 1367–1369, 1977.
14.
HughesJ.: Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.Brain Res, 88: 293–308, 1975.
15.
HughesJ., SmithT.W., KosterlitzH.N., FothergillL.A., MorganB.A., MorrisH.R.: Identification of two related pentapeptides from the brain with potent opiate agonist activity.Nature, 258: 577–579, 1975.
16.
KlineN.S., LiC.H., LehmannH.E.,: B-endorphin induced changes in schizophrenic and depressed patients.Arch Gen Psychiatry, 34: 111–113, 1977.
17.
KosterlitzH.W., HughesJ.: Peptides with morphine-like action in the brain.Br J Psychiatry, 130: 298–304, 1977.
18.
KosterlitzH.W., HughesJ.: Some thoughts on the significance of enkephalin, the endogenous ligand.Life Sci, 17: 91–96, 1975.
19.
LehmannH., NairN.P.V., KlineN.S.: B-endorphin and naloxone in psychiatric patients: Clinical biological effects.Am J Psychiatry, 136: 762–766, 1979.
20.
LevineJ.D., GordonN.C., FieldsH.L.: The mechanism of placebo analgesia.Lancet, Sept. 23, 1978, pp. 654–655.
21.
LiC.H., BarnafiL., ChrétienM., ChongD.: Isolation and amino acid sequence of beta LPH from sheep pituitary glands.Nature, 208: 1093, 1965.
22.
LiC.H.: Chemical messengers of the adenohypophysis from somatotropin to lipotropin.Perspect Biol Med, 21: 447–465, 1978.
23.
LiC.H.: Human somatotropin and lipotropin: relation between structure and activity.Can Med Assoc J, 120: 575–578, 1979.
24.
LindstromL.H., WiderlovE., GunneL.M., WahlstromA., TereniusL.: Endorphins in human cerebrospinal fluid: Chemical correlations to some psychotic states.Acta Psychiatr Scand, 57: 153–164, 1978.
25.
LingN., BurgusR., GuilleminR.: Isolation, primary structure and synthesis of alpha endorphin and gamma endorphin, two peptides of hypothalamic-hypophyseal origin with morphomimetic activity.Proc Natl Acad Sci USA, 73: 3942–3946, 1976.
26.
MayerD.J., PriceD.D., RaftiA.: Acupuncture analgesia in man reversed by the narcotic antagonist naloxone.Brain Res, 121: 365–372, 1977.
27.
PalmourR., ErvinF., WagemakerH.,: “Characterization of a Peptide from the Serum of Psychotic Patients” in, UsdinE., BunneyW.E., KlineN.S., (eds): Endorphins in Mental Health Research.London: MacMillan, 1978.
PomeranzB.: Acupuncture analgesia in mice blocked by naloxone or hypophysectomy.Exp Neurol, 54: 172–178, 1977.
30.
RivierC., ValeW., LingN., BrownM., GuilleminR.: Stimulation in vivo of the secretion of prolactin and growth hormone by B-endorphin.Endocrinology, 100: 238–241, 1977.
SnyderG.H.: The opiate receptor and morphine-like peptides of the brain.Am J Psychiatry, 135: 645–652, 1978.
34.
SnyderG.H.: Opiate receptors and internal opiates.Sci Am, 236: 44–56, 1977.
35.
SimonE.J., HillerJ.M., EdelmanI.: Stereospecific binding of the potent narcotic analgesia (3H) exorphine to rat brain homogenate.Proc Natl Acad Sci USA, 70: 1947–1949, 1973.
36.
TereniusL., WahlstromA.: Search for an endogenous ligand for the opiate receptor.Acta Physiol Scand.94: 74–81, 1975.
37.
VerebyK., VolavkaJ., CourtD.: Endorphins in psychiatry.Arch Gen Psychiatry, 35: 877–888, 1978.
38.
Verhoeven WimM.A., van PraagH.M., BotterP.A.,GunierA., van ReeJ.M., de WiedD.: [Des-Tyr1]-y endorphin in schizophrenia.Lancet, May 13, 1978, pp. 1046–1047.
39.
Verhoeven WimM.A., van PraagH.M., van ReeJ.M., de WiedD.: Improvement of schizophrenic patients treated with [Des-Tyr1]-y endorphin (DTyE).Arch Gen Psychiatry, 36: 294–298, 1979.
40.
WagemakerH., CadeR.: The use of hemodialysis in chronic schizophrenia.Am J Psychiatry, 134: 684–685, 1977.